It has been reported that inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) in the TME are able to enhance PD-L1 expression in cancer cells [23,24], contributing to escape from T cell immune surveillance. The gene discussed is CD274; the disease is cancer.